Demography	Cholesterol	Blood pressure	Risk factors
Age: 65	Total: 170	Systolic: 115	Diabetes: no
Gender: male	HDL: 70	Diastolic: 75	Smoking: no
Race: not African-American		On medication: no

Notes and further reading

• Moderate intensity statin may be atorvastatin 10mg, pravastatin 40mg, or simvastatin 20-40mg. High intensity statin may be atorvastatin 40mg-80mg.
• AHA/ACC guidelines stress the importance of lifestyle modifications to lower cardiovascular disease risk in all patients. This includes eating a heart-healthy diet, regular aerobic exercises, maintenance of desirable body weight and avoidance of tobacco products.
• Before initiating statin therapy, clinicians and patients ought to engage in a discussion which considers addressing risk factors such as smoking and optimal lifestyle, the potential for ASCVD risk reduction benefits, adverse medication effects, drug-drug interactions, and patient preferences for treatment.
• ASCVD Risk Enhancers may be used to inform treatment decision making and include family history of premature ASCVD with onset less than 55 years of age in a first degree male relative or less than 65 years of age in a first degree female relative, chronic kidney disease, metabolic syndrome, certain conditions specific to women (eg preeclampsia), inflammatory disease (especially rheumatoid arthritis, psoriasis, HIV), ethnicity (eg South Asian ancestry), persistently elevated LDL-C greater than 160 mg/dL, persistently elevated triglycerides of greater than 175 mg/dL, high-sensitivity C-reactive protein greater than 2 mg/L, coronary artery calcification score greater than 75th percentile for age, sex, and ethnicity, or ankle-brachial index less than 0.9.